Maze Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Maze Therapeutics, Inc.
CIK #0001842295
EDGAR Form CIK 2011 - 2025
10-K [0001842295]
10-Q [0001842295]
3 [0001842295]
4 [0001842295]
8-K [0001842295]
SC 13G [0001842295]
Form 13D/13G Filer Form 13D/13G Subject Filed
Arch Venture Fund X LP MAZE Therapeutics Inc [2025-05-15]
Matrix Capital Management Company LP MAZE Therapeutics Inc [2025-05-14]
Janus Henderson Group PLC MAZE Therapeutics Inc [2025-05-14]
Third Rock Ventures IV LP MAZE Therapeutics Inc [2025-05-09]
GV 2019 LP MAZE Therapeutics Inc [2025-05-09]
Frazier Life Sciences Public Fund LP MAZE Therapeutics Inc [2025-02-10]
Foresite Capital Fund IV LP MAZE Therapeutics Inc [2025-02-07]
Deep Track Capital LP MAZE Therapeutics Inc [2025-02-07]
Foresite Capital Fund IV LP MAZE Therapeutics Inc [2025-02-07]
Form 3/4/5 Subject 2011 - 2025
Exter Neil
Maze Therapeutics, Inc.
Third Rock Ventures IV, L.P.
Third Rock Ventures GP IV, L.P.
Third Rock Ventures V, L.P.
TRV GP V LLC
TRV GP IV LLC
Third Rock Ventures GP V, LP
Homcy Charles J
Lim Jonathan E
Bernstein Harold
Courtney Phillips
Andrews Nancy C
Brush James
Colowick Alan
Kathiresan Sekar
Scheller Richard H
Sohn Catherine A.
Spiegelman Daniel K
Tong Jeffrey K
ARCH Venture Fund X, L.P.
ARCH Venture Fund X Overage, L.P.
ARCH Venture Partners X, LLC
Crandell Keith
Gillis Steven
ARCH Venture Partners X, L.P.
ARCH Venture Partners X Overage, L.P.
Nelsen Robert
Burow Kristina
Coloma Jason V
Dandekar Atul
Bachrodt Amy
Terms | Privacy | Guide
tony@aum13f.com